Latest Pseudomonas aeruginosa Stories
OKLAHOMA CITY, May 20, 2015 /PRNewswire/ -- Synereca Pharmaceuticals, Inc.
TEMPE, Ariz., April 6, 2015 /PRNewswire/ -- Procellera(®) from Vomaris Innovations, Inc.
Study Expected to Complete in 4Q 2015 SAN JOSE, Calif., March 26, 2015 /PRNewswire/ -- Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to
Patent awarded on Feb.
RnRMarketResearch.com adds "Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014" to its store.
Study Does Not Meet Primary Endpoint SOUTH SAN FRANCISCO, Calif., Jan. 6, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.
- Potential Treatment for Hospitalized Patients with Complicated Intra-Abdominal and Complicated Urinary Tract Infections - DUBLIN, Dec.
KB004 Phase 1/2 Clinical Data in Hematologic Malignancies to be presented at the 56th American Society of Hematology Annual Meeting and Exposition SOUTH SAN FRANCISCO, Calif., Nov.
The Oliver Law Group P.C.
Pseudomonas aeruginosa is a common bacterium that can cause disease in animals and humans. It can be found in soil, water, skin flora, and most man-made environments throughout the world. It thrives in normal or hypoxic atmospheres; due to this it has colonized many natural and artificial environments. It can infect animals with damaged tissue or people with reduced immunity. Symptoms are generalized inflammation and sepsis. It can be fatal if colonization occurs in critical body organs,...
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.